Eisai Co., Ltd.

    Jurisdiction
    Japan
    LEI
    353800HDEE0ZYEX4QV91
    ISIN
    JP3160400002 (4523.T)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    53 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €39.44 50.9% undervalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Eisai Co., Ltd. offers pharmaceutical products in Japan. Read full profile

    Fundamentals

    Net revenue
    €4.56B
    Gross margin
    78.6%
    EBIT
    €268.11M
    EBIT margin
    5.9%
    Net income
    €268.23M
    Net margin
    5.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A N/A
    N/A N/A
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    ¥80.00
    Ex date
    Payment date
    Dividend payout ratio
    98.1%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications